Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hartnett

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Paediatrics & Child Health|December 19, 2009
Orthotopic liver transplantation in a patient with carbamyl phosphate synthetase deficiency and cystic fibrosisS Sirrs, E M Yoshida, Ltk Wong, et al.
Nano Letters|December 31, 2013
Hierarchical nanoparticle ensembles synthesized by liquid phase directed self-assemblyJ D Fowlkes, N A Roberts, Y Wu, et al.
Receptors & Channels|January 1, 1996
Effect of subunit composition on GABAA receptor complex characteristics in a baculovirus expression systemC Hartnett, M S Brown, J Yu, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Optimization of 2,3,5-trisubstituted pyridine derivatives as potent allosteric Akt1 and Akt2 inhibitorsJohn C Hartnett, Stanley F Barnett, Mark T Bilodeau, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
Development of pyridopyrimidines as potent Akt1/2 inhibitorsZhicai Wu, John C Hartnett, Lou Anne Neilson, et al.
Nature Chemistry|April 27, 2021
Superatomic solid solutionsJingjing Yang, Jake C Russell, Songsheng Tao, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Imidazopyridine CB2 agonists: optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacyB Wesley Trotter, Kausik K Nanda, Christopher S Burgey, et al.
Journal of the Advanced Practitioner in Oncology|October 6, 2022
Management of Adverse Events in Early Clinical Trials by Advanced Practice Providers in the Outpatient Setting: The University of Texas MD Anderson Cancer Center ExperienceFedricker D Barber, Erick Campbell, Yuko Yamamura, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Paediatrics & Child Health|December 19, 2009
Orthotopic liver transplantation in a patient with carbamyl phosphate synthetase deficiency and cystic fibrosisS Sirrs, E M Yoshida, Ltk Wong, et al.
Nano Letters|December 31, 2013
Hierarchical nanoparticle ensembles synthesized by liquid phase directed self-assemblyJ D Fowlkes, N A Roberts, Y Wu, et al.
Receptors & Channels|January 1, 1996
Effect of subunit composition on GABAA receptor complex characteristics in a baculovirus expression systemC Hartnett, M S Brown, J Yu, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Optimization of 2,3,5-trisubstituted pyridine derivatives as potent allosteric Akt1 and Akt2 inhibitorsJohn C Hartnett, Stanley F Barnett, Mark T Bilodeau, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
Development of pyridopyrimidines as potent Akt1/2 inhibitorsZhicai Wu, John C Hartnett, Lou Anne Neilson, et al.
Nature Chemistry|April 27, 2021
Superatomic solid solutionsJingjing Yang, Jake C Russell, Songsheng Tao, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Imidazopyridine CB2 agonists: optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacyB Wesley Trotter, Kausik K Nanda, Christopher S Burgey, et al.
Journal of the Advanced Practitioner in Oncology|October 6, 2022
Management of Adverse Events in Early Clinical Trials by Advanced Practice Providers in the Outpatient Setting: The University of Texas MD Anderson Cancer Center ExperienceFedricker D Barber, Erick Campbell, Yuko Yamamura, et al.
Pageof 6